Bunge Limited, Inc.

Bunge Limited, Inc. (NYSE: BG), relating to its proposed merger with Viterra Limited.

Wireless Telecom Group, Inc.

Wireless Telecom Group, Inc. (NYSE: WTT), relating to its proposed sale to Maury Microwave, Inc. Under the terms of the agreement, WTT shareholders are expected to receive $2.13 in cash per share they own.

Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), relating to its proposed sale to Gurnet Point Capital and Novo Holdings A/S. Under the terms of the agreement, PRTK shareholders are expected to receive $2.15 in cash per share they own and a contingent value right worth up to $0.85 per share.

Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc. (NASDAQ: KDNY), relating to its proposed sale to Novartis AG. Under the terms of the agreement, KDNY shareholders are expected to receive $40.00 in cash per share they own and contingent value rights worth up to $4.00 per share.

Reunion Neuroscience Inc.

Reunion Neuroscience Inc. (NASDAQ: REUN), relating to its proposed sale to affiliates of MPM BioImpact. Under the terms of the agreement, REUN shareholders will receive $1.12 in cash per share they own.

CIRCOR International, Inc.

CIRCOR International, Inc. (NYSE: CIR), relating to its proposed sale to funds managed by KKR. Under the terms of the agreement, CIR shareholders will receive $49.00 in cash per share they own.

CohBar, Inc.

CohBar, Inc. (NASDAQ: CWBR), relating to its proposed merger with Morphogenesis, Inc.

Greenhill & Co., Inc.

Greenhill & Co., Inc. (NYSE: GHL), relating to its proposed sale to Mizuho Financial Group, Inc. Under the terms of the agreement, GHL shareholders are expected to receive $15.00 in cash per share they own.

Syneos Health, Inc.

Syneos Health, Inc. (NASDAQ: SYNH), relating to its proposed sale to Elliott Investment Management, Patient Square Capital, and Veritas Capital. Under the terms of the agreement, SYNH shareholders are expected to receive $43.00 in cash per share they own.